Home Synthesis and crystal structure of methyl 2-(2-((tert-butoxycarbonyl)amino)phenyl)-2-(4-oxo-4H-chromen-3-yl)acetate, C23H23NO6
Article Open Access

Synthesis and crystal structure of methyl 2-(2-((tert-butoxycarbonyl)amino)phenyl)-2-(4-oxo-4H-chromen-3-yl)acetate, C23H23NO6

  • Wu-Wu Li ORCID logo EMAIL logo and Xiong-Li Liu
Published/Copyright: August 21, 2020

Abstract

C23H23NO6, monoclinic, P21/n (no. 14), a = 7.5845(4) Å, b = 14.7024(5) Å, c = 18.1433(6) Å, β = 98.753(4)°, V = 1999.62(14) Å3, Z = 4, Rgt(F) = 0.0389, wRref(F2) = 0.0965, T = 293 K.

CCDC no.: 2022661

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.13 × 0.12 × 0.11 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.10 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:25.0°, >99%
N(hkl)measured, N(hkl)unique, Rint:12760, 3510, 0.033
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2963
N(param)refined:279
Programs:SHELX [1], Bruker [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.71916(17)0.66626(8)0.54853(6)0.0256(3)
O20.58388(16)0.50290(7)0.36722(6)0.0221(3)
O30.85285(15)0.66269(7)0.23708(6)0.0217(3)
O40.57052(17)0.66172(8)0.17288(6)0.0293(3)
O50.83680(15)0.79430(7)0.42312(6)0.0210(3)
O60.66384(16)0.87639(7)0.48784(6)0.0227(3)
N10.65063(19)0.75055(9)0.27585(7)0.0179(3)
H10.734(3)0.7555(12)0.3139(10)0.026(5)*
C10.5813(2)0.64917(10)0.42435(8)0.0172(3)
C20.6808(2)0.61601(11)0.49421(8)0.0186(4)
C30.7328(2)0.51983(10)0.49408(9)0.0190(4)
C40.8356(2)0.47897(11)0.55594(9)0.0225(4)
H40.8662150.5119650.5997540.027*
C50.8915(2)0.39057(11)0.55227(10)0.0252(4)
H50.9588150.3636780.5936810.030*
C60.8474(2)0.34096(11)0.48651(10)0.0270(4)
H60.8884540.2815980.4840230.032*
C70.7443(2)0.37865(11)0.42545(10)0.0246(4)
H70.7135670.3451260.3819140.030*
C80.6864(2)0.46806(11)0.42995(9)0.0203(4)
C90.5358(2)0.59178(10)0.36736(9)0.0192(4)
H90.4660200.6144900.3247350.023*
C100.5288(2)0.74868(10)0.42356(8)0.0169(3)
H100.4559810.7566790.4633040.020*
C110.4180(2)0.78384(10)0.35211(8)0.0168(3)
C120.2487(2)0.81868(10)0.35582(9)0.0198(4)
H120.2082320.8209040.4016650.024*
C130.1397(2)0.84994(11)0.29313(9)0.0232(4)
H130.0268530.8726070.2967620.028*
C140.1994(2)0.84735(11)0.22476(9)0.0231(4)
H140.1258140.8676700.1822440.028*
C150.3676(2)0.81477(10)0.21935(9)0.0203(4)
H150.4074250.8140280.1733370.024*
C160.4780(2)0.78301(10)0.28248(8)0.0169(3)
C170.6812(2)0.68863(10)0.22313(8)0.0191(4)
C180.9195(2)0.59164(11)0.19078(9)0.0221(4)
C190.8202(3)0.50357(12)0.19828(10)0.0320(4)
H19A0.8255840.4888440.2501270.048*
H19B0.8742520.4555780.1736310.048*
H19C0.6979070.5104450.1758490.048*
C201.1134(2)0.58349(12)0.22529(10)0.0297(4)
H20A1.1717590.6409850.2220800.044*
H20B1.1705530.5382050.1990090.044*
H20C1.1209310.5661250.2766830.044*
C210.9039(3)0.62367(13)0.11039(9)0.0324(5)
H21A0.7805150.6331110.0905680.049*
H21B0.9532180.5784330.0812800.049*
H21C0.9680470.6797060.1085560.049*
C220.6954(2)0.80687(10)0.44475(8)0.0174(4)
C230.8152(3)0.93334(12)0.51410(10)0.0305(4)
H23A0.8687860.9538310.4724200.046*
H23B0.9009020.8991760.5474570.046*
H23C0.7765750.9849130.5399030.046*

Source of material

The mixture of tert-butyl 3-(methylsulfonyloxy)-2-oxo-3-(4-oxo-3,4-dihydro-2H-chromen-3-yl) indoline-1-carboxylate (0.1 mmol), Et3N (0.12 mmol) and MeOH (methanol; 3 mL) was stirred at room temperature for about 2 h. The reaction was monitored by thin-layer chromatography, which showed the disappearance of tert-butyl 3-(methylsulfonyloxy)-2-oxo-3-(4-oxo-3,4-dihydro-2H-chromen-3-yl) indoline-1-carboxylate. After MeOH was removed under reduced pressure, the residue was purified by column chromatography on silica gel column using petroleum ether/ethyl acetate (8:1, v/v) to give the pure title compound. Crystals were obtained at room temperature from the mother liquor.

Experimental details

All hydrogen atoms placed in geometrically idealized positions. The Uiso values of the hydrogen atoms of methyl groups were set to 1.5Ueq(C) and the Uiso values of all other hydrogen atons were set to 1.2Ueq(C).

Comment

Synthesis of heterocyclic compounds has emerged as a powerful technique useful for drug discovery [3]. In particular, synthesis of heterocycles bearing oxygen atom(s) is an important synthetic target, as they are integral parts of many medicinally interesting compounds. The chromen-4-one is an important oxygen-containing heterocycle which may possess variety of biological activities, such as antiHIV [4], [5], anticancer [6], [7] and antioxidant [8], [9].

As shown in Figure, the title compound is composed of two molecular moieties: 4H-chromen-4-one and methyl 2-(2-(tert-butoxycarbonyl)phenyl)acetate, the two moieties are linked by C10. The 4H-chromen-4-one moiety is essentially planar, with mean deviation from this plane of 0.0312(3) Å, and the chemical bond parameters of it are consistent with previous reports [10], [11]. The dihedral angle between the two ring moieties is 57.9°. The molecular skeleton is stabilized by an intra-molecular hydrogen bond N1—H1⋯O5.

Acknowledgements

This research was supported by Scientific Research Program Funded by Shaanxi Provincial Education Department (No. 18JK0837), Natural Science Basic Research Plan Funded by Shaanxi Province of China (No. 2018JM2045), Science and Technology Projects of Xianyang City (No. 2017k02–19), Scientific Research Project Funded by Xianyang Normal University (No. XSYK18006) and Qing-Lan Talents Project Funded by Xianyang Normal University (No. XSYQL201904).

References

1. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar

2. Bruker. APEX2 and SAINT. Bruker AXS Inc., Madison, WI, USA (2012).Search in Google Scholar

3. Hermkens, P. H. H.; Ottenheijm, H. C. J.; Rees, D. C.: Solid-phase organic reactions II: a review of the literature Nov95-Nov96. Tetrahedron 53 (1997) 5643–5678.10.1016/S0040-4020(97)00279-2Search in Google Scholar

4. Flavin, M. T.; Rizzo, J. D.; Khilevich, A.; Kucherenko, A.; Sheinkman, A. K.; Vilaychack, V.; Lin, L.; Chen, W.; Greenwood, E. M.; Pengsuparp, T.; Pezzuto, J. M.; Hughes, S. H.; Flavin, T. M.; Cibulski, M.; Boulanger, W. A.; Shone, R. L.; Xu, Z. Q.: Synthesis, chromatographic resolution, and anti–human immunodeficiency virus activity of (±)-calanolide A and its enantiomers. J. Med. Chem. 39 (1996) 1303–1313.10.1021/jm950797iSearch in Google Scholar

5. Ishikawa, T.; Oku, Y.; Tanaka, T.; Kumamoto, T.: An approach to anti-HIV-1 active calophyllum coumarin synthesis: an enantioselective construction of 2,3-dimethyl-4-chromanone ring by quinine-assisted intramolecular Michael-type addition. Tetrahedron Lett. 40 (1999) 3777–3780.10.1016/S0040-4039(99)00607-3Search in Google Scholar

6. Zheng, X.; Meng, W. D.; Xu, Y. Y.; Cao, J. G.; Qing, F. L.: Synthesis and anticancer effect of chrysin derivatives. Bioorg. Med. Chem. Lett. 13 (2003) 881–884.10.1016/S0960-894X(02)01081-8Search in Google Scholar

7. Gobbi, S.; Rampa, A.; Bisi, A.; Belluti, F.; Piazzi, L.; Valenti, P.; Zaputo, A.; Zampiron, A.: Synthesis and biological evaluation of 3-alkoxy analogues of flavone-8-acetic acid. J. Med. Chem. 46 (2003) 3662–3669.10.1021/jm030771oSearch in Google Scholar PubMed

8. Rackova, L.; Firakova, S.; Kostalova, D.; Stefek, M.; Sturdik, E.; Majekova, M.: Oxidation of liposomal membrane suppressed by flavonoids: quantitative structure-activity relationship. Bioorg. Med. Chem. 13 (2005) 6477–6484.10.1016/j.bmc.2005.07.047Search in Google Scholar PubMed

9. Hatzade, K.; Sheikh, J.; Taile, V.; Ghatole, A.; Ingle, V.; Genc, M.; Lahsasni, S.; Hadda, T. B.: Antimicrobial/antioxidant activity and POM analyses of novel 7-o-β-D-glucopyranosyloxy-3-(4,5-disubstitutedimidazol-2-yl)-4H-chromen-4-ones. Med. Chem. Res. 24 (2015) 2679–2693.10.1007/s00044-015-1326-8Search in Google Scholar

10. Li, W. W.; Zhang, Z. T.: Synthesis, crystal structure andantitumor activity of tectochrysin-6-sulfonate. Chin. J. Struct. Chem. 37 (2018) 97–104.Search in Google Scholar

11. Meng, J. P.; Lei, J.: Crystal structure of (E)-N-(2-(benzylamino)-2-oxo-1-(4-oxo-4H-chromen-3-yl)ethyl)-N-(4-bromophenyl)-3-chloroacrylamide hydrate, C27H22BrClN2O5. Z. Kristallogr. NCS 233 (2018) 589–590.10.1515/ncrs-2017-0346Search in Google Scholar

Received: 2020-07-16
Accepted: 2020-08-11
Published Online: 2020-08-21
Published in Print: 2020-10-27

©2020 Wu-Wu Li et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Crystal structure of poly[tetraaqua-bis(μ4-5-(4-carboxy-benzylamino)-isophthalato-κ4O,O′:O′′:O′′′)-(μ2-4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl-κ2N:N′)dicadmium(II)], C25H22N3O8Cd
  3. The crystal structure of 2-(2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-ium-1-yl)phenoxy)acetate, C19H18N2O3
  4. Crystal structure of poly[aqua-μ2-4,4′-bipyridine-κ2N:N′)-μ2-bis(2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ2O,O′)zinc(II)], C38H28Cl4N4O4Zn
  5. Crystal structure of 1-(2-(1H-indol-3-yl)ethyl)-4-benzyl-3-hydroxy-3,6-diphenylpiperazine-2,5-dione, C33H29N3O3
  6. The crystal structure 2,2′-bipyridine-κ2N,N′-(2-(3-amino-4-chlorobenzoyl)benzoato-κ1O)-(2-(3-amino-4-chlorobenzoyl)benzoato-κ2O,O′)zinc(II) — ethanol (1/1), C40H32Cl2N4O7Zn
  7. Crystal structure of catena-poly[(μ3-2-carboxy-4-(3-carboxy-5-carboxylatophenoxy)benzoato-κ3O:O′:O′′)-bis(μ2-4,4′-bis(pyrid-4-yl)biphenyl-k1N)copper(II)], C60H40N4O9Cu
  8. The crystal structure of dimethylammonium catena-[di(μ-aqua)-bis(μ9-benzene-1,3,5-tricarboxylato)pentalithium], C20H16Li5NO13
  9. Crystal structure of tetraaqua-bis(3,5-di(pyridin-4-yl)-1,2,4-triazol-1-ido-κ1N)nickel(II) dihydrate, C24H28O6N10Ni
  10. The crystal structure of tetrakis(1-methylimidazole-κ1N)-oxido-(sulfato-κ1O)vanadium(IV), C16H24N8O5SV
  11. Crystal structure of methyl 2-(6,11-dioxo-2,3,6,11-tetrahydro-1H-benzo[f]pyrrolo[2,1-a]isoindole-5-carbonyl)benzoate, C24H17NO5
  12. Crystal structure of (E)-N′-(2-hydroxy-4-(2-(piperidin-1-yl)ethoxy)benzylidene) nicotinohydrazide monohydrate, C20H24N4O3 ⋅ H2O
  13. Crystal structure of poly[bis(μ3-(1-(3,5-di(1H-imidazol-1-yl)phenyl)-1H-imidazole-κ3N:N′:N′′)cobalt(II)] dinitrate — N,N-dimethylformamide (1/4), C42H52N18O10Co
  14. The crystal structure bis{hexakis(1-methyl-1H-imidazole-κ1N)cobalt(II)} tetrakis(μ3-oxido)-octakis(μ2-oxido)-tetradecaoxido-octamolybdate(VI), C24H36CoMo4N12O13
  15. Crystal structure of di-μ-nicotinato-κ2N:O; κ2O:N-bis-[aqua-bis(benzyl)(nicotinato-κ2O,O′)tin(IV)], C52H48N4O10Sn2
  16. Crystal structure of dichlorido-bis[2-(2-(3-(pyridin-2-yl)-1H-1,2,4-triazol-5-yl)phenoxy)benzoic acidmanganese(II) monohydrate, C40H30N8O7MnCl2
  17. The crystal structure of benzyl 3β-acetylglycyrrhetate, C39H54O5
  18. Synthesis and crystal structure of (E)-1-benzyl-3-(4-methoxystyryl)quinoxalin-2(1H)-one, C24H20N2O2
  19. Crystal structure of trans-dichloridobis(4-chlorophenyl-κC1)(1,10-phenanthroline-κ2N,N′)tin(IV) dimethylsulphoxide solvate, C26H22Cl4N2OSSn
  20. Crystal structure of phenyl(1,3,4a-triphenyl-4a,5,6,10b-tetrahydro-1H-[1,4]oxazino[2,3-c]quinolin-5-yl)methanone, C36H28N2O2
  21. Crystal structure of (4aS,5S,6aS,6a1S, 10aS)-4a,5,6a,6a1,9,10-hexahydro-7H-4,5-methanocyclobuta[4,5]naphtho[8a,1-b]pyran-6(2H)-one, C15H16O2
  22. Crystal structure of [(Z)-O-isopropyl N-(4-chlorophenyl)thiocarbamato-κS]-(triphenylphosphine-κP)-gold(I), C28H26AuClNOPS
  23. Crystal structure of (μ2-1,1′-bis(diphenylphosphino)ferrocene-P,P′)-bis[(Z)-O-isopropyl N-(4-chlorophenyl)thiocarbamato-S]-di-gold(I) acetonitrile di-solvate, C54H50Au2Cl2FeN2O2P2S2⋅2(C2H3N)
  24. Crystal structure of (6aR,6a1S,10aS)-2,4a,6a,6a1,9,10-hexahydro-7H-4,5-methanocyclobuta[4,5]naphtho[8a,1-b]pyran, C15H16O
  25. Crystal structure of 5,17-diformyl-25,26,27,28-tetrahydroxycalix[4]arene- dichloromethane, C31H26Cl2O6
  26. Crystal structure of 2-tert-butyl 1-methyl 5-{4-[(methoxycarbonyl)amino]phenyl}-2,5-dihydro-1H-pyrrole-1,2-dicarboxylate, C19H24N2O6
  27. Crystal structure of [2-carboxybenzene-1-thiolato-S]-(triethylphosphane-P)-gold(I), C13H20AuO2PS
  28. Synthesis and crystal structure of bis(5-methyl-2-aldehyde-phenolato-κ2O1,O2)copper(II), C16H14CuO4
  29. Crystal structure of poly[triaqua-(di(2,2′-bipyridine-κ2N,N′)-μ4-silanetetrayltetrakis(benzene-4,1-diyl)tetrakis (hydrogen phosphonato)-κ4O:O′:O′′:O′′′) dicadmium(II)], C44H42N4O15P4Cd2Si
  30. Crystal structure of bis[μ2-(N,N-diethylcarbamodithioato-κSSS′)]-bis(triethylphosphine-P)-di-silver(I), C22H50Ag2N2P2S4
  31. Crystal structure of bis[μ2-(pyrrolidine-1-carbodithioato-κSSS′)]-bis(triethylphosphine-κP)disilver(I), C22H46Ag2N2P2S4
  32. Crystal structure of bis[μ2-(N-(2-hydroxyethyl)-N-methylcarbamodithioato-κSSS′)]-bis(triethylphosphine-P)-di-silver(I), C20H46Ag2N2O2P2S4
  33. The crystal structure of (2E,2′E)-,2,2′-bis[1-(2-pyrazinyl)ethylidene]carbonimidic dihydrazide, C13H15N9
  34. The crystal structure of (E)-1-(quinolin-2-ylmethyl)-2-((1-(quinolin-2-ylmethyl)pyridin-2(1H)-ylidene)amino)pyridin-1-ium, C30H25BrN5
  35. Crystal structure of catena-poly[(μ2-1-((benzotriazol-1-yl)methyl)-1H-1,3-imdazole-κ2N:N′)-(1-((benzotriazol-1-yl)methyl)-1H-1,3-imdazole-κ1N)-(methanol-κ1O)mercury(II)] dinitrate, C21H22N12O7Hg
  36. Crystal structure of 1-(6-hydroxy-2-phenylbenzofuran-5-yl)ethan-1-one, C16H12O3
  37. The crystal structure of oxonium hexaquaaluminium disulfate hexahydrate
  38. Crystal structure of catena{(μ2-1,10-phenanthroline-κ4N,N,N′,N′)-(μ2-1,10-phenanthroline-κ3N,N,N′)potassium(I) {[bis(2-hydroxyethyl)iminiumyl](sulfanidyl)methyl}sulfanide hemi(1,10-phenanthroline)}, {C24H16KN4, 0.5(C12H8N2), C5H10NO2S2}
  39. Crystal structure of chlorido-[(N,N-di-isobutyl)dithiocarbamato-κ2S,S′]-di(4-methylbenzyl-κC)tin(IV), C25H36ClNS2Sn
  40. Crystal structure of chlorido-(η5-pentamethylcyclopentadienyl)-(4-chloro-4-pyridyl-2,2′:6′,2′′-terpyridine-κ2N,N′) rhodium(III) hexaflourophosphate, C31H29Cl2F6N3PRh
  41. The crystal structure of catena-poly[bis-(3,5-dinitro-1,2,4-triazolato-κ2N:O)-(μ2-1,4-bis(1-imidazolyl)benzene-κ2N:N′)copper(II)], C16H10CuN14O8
  42. Crystal structure of poly[triaqua-bis(μ3-3,3′-((5-carboxylato-1,3-phenylene)bis(oxy))dibenzoato)-tris(1,10-phenanthroline)cobalt(II)], C78H46N6O20Co3
  43. The crystal structure of 2,4-dihydroxybenzoic acid–nicotinamide–methanol (1/1/1), C15H18N2O6
  44. The crystal structure of aqua{N,N,N′,N′-tetrakis[(1H-benzimidazol-κN3) methyl]cyclohexane-1,2-diamine}lead(II) diacetate–methanol (1/2), C44H54N10O7Pb
  45. Crystal structure of (2-amino-5-bromo-3-iodophenyl)(3-(4-chlorophenyl)oxiran-2-yl)methanone, C15H10BrClINO2
  46. Synthesis and crystal structure of 3-octyl-5,5-diphenylimidazolidine-2,4-dione, C23H28N2O2
  47. Synthesis and crystal structure of 2-azido-N-(4-nitrophenyl)acetamide, C8H7N5O3
  48. Crystal structure of tert-butyl (1S,2R,5R)-2-(hydroxymethyl)-4-(4-methoxyphenyl)-6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate, C17H23NO5
  49. Crystal structure of 4-[(4-methoxy-2-nitrophenyl)carbamoyl]butanoic acid, C12H14N2O6
  50. Crystal structure of 3-ethyl-1-[(E)-[(2E)-3-phenylprop-2-en-1-ylidene]amino]thiourea, C12H15N3S
  51. Crystal structure of 4,4′-bipyridin-1,1′-dium poly[bis(μ4-benzene-1,3,5-triyltris(hydrogen phosphonato-κ4O:O′:O′′:O′′′))zinc(II)], C11H11NO9P3Zn
  52. Crystal structure of (μ2-1,1′-bis(diphenylphosphino)butane-κ2P,P′)-bis[(Z)-N-(3-fluorophenyl)-O-methylthiocarbamato-κS]-di-gold(I), C44H42Au2F2N2O2P2S2
  53. Crystal structure of (μ2-1,1′-bis(diphenylphosphino)hexane-κ2P,P′)-bis[(Z)-N-(3-fluorophenyl)-O-methylthiocarbamato-κS]digold(I), C46H46Au2F2N2O2P2S2
  54. Crystal structure of tetrakis (N-(2-hydroxyethyl)-N-isopropylcarbamodithioato-κS,S′)-(μ2(2-(pyridin-4-yl)vinyl)pyridine-κN,N′)dicadmium(II), C36H58Cd2N6O4S8
  55. Crystal structure of 4-(2-(benzo[b]thiophen-2-yl)-3,3,4,4,5,5-hexafluorocyclopent-1-en-1-yl)-1,5-dimethyl-1H-pyrrole-2-carbonitrile, C20H12F6N2S
  56. Crystal structure of bis(octahydrocyclopenta[c]pyrrolium)pentachlorobismuthate(III), (C7NH14)2BiCl5
  57. The crystal structure of diaqua-tris(nitrato-κ2O,O′)-bis(4,4,5,5-tetramethyl-2-(p-pyridyl)imidazoline-1-oxyl 3-oxide-κN)samarium(III), C24H36N9O15Sm
  58. Synthesis and crystal structure of methyl 2-(2-((tert-butoxycarbonyl)amino)phenyl)-2-(4-oxo-4H-chromen-3-yl)acetate, C23H23NO6
  59. Crystal structure of O-hexyl benzoylcarbamothioate, C14H19NO2S
  60. Crystal structure of chlorido-(O-methyl phenylcarbamothioamide-κS)-bis(triphenylphosphane-κP)silver(I), C44H39AgClNOP2S
  61. Crystal structure of chlorido-(O-ethyl phenylcarbamothioamide-κS)-bis(triphenylphosphane-κP)-silver(I), C45H41AgClNOP2S
  62. Crystal structure of 4-[(2-methoxyphenyl)carbamoyl]butanoic acid, C12H15NO4
  63. Crystal structure of ethyl 4-methyl-2-oxo-5-phenyl-1,3,4-oxadiazinane-3-carboxylate, C13H16N2O4
  64. Crystal structure of catena-poly[diaqua(μ2-2-(hydroxymethyl)-1H-imidazole-4,5-dicarboxylato)cadmium(II)], C6H8CdN2O7
  65. Crystal structure of (1S)-N-(chloromethyl)-1-((4S,6aR,8aS, 8bR,9aR)-4-methoxy-6a,8a-dimethyl-1,3,4, 5,6,6a,6b,7,8,8a,9a,10,10a,10b-tetradecahydro-8bH-naphtho[2′,1′:4,5] indeno[1,2-b]oxiren-8b-yl)-N-methylethan-1-amine, C24H46ClNO5
  66. Crystal structure of 4-[(3,5-dichlorophenyl)carbamoyl]butanoic acid, C11H11Cl2NO3
  67. Crystal structure of (2Z)-2-amino-3-[(E)-[(2,4-dihydroxyphenyl)methylidene]-amino]but-2-enedinitrile, C11H8N4O2
  68. Crystal structure of 3-methyl-1-[(E)-(4-phenylbutan-2-ylidene)amino]thiourea, C12H17N3S
  69. Crystal structure of carbonyl{hydridotris[3-phenyl-5-methylpyrazol-1-yl]borato-κ3N,N′N′′}copper(I), C31H28BCuN6O
  70. Crystal structure of ethane-1,2-diylbis(diphenylphosphine oxide) – dihydrogenperoxide (1/2), C26H28O6P2
  71. Crystal structure of 2-(pyridin-2-ylamino)pyridinium chloride dibenzyldichlorostannane, [C10H10N3]Cl, C14H14Cl2Sn
  72. Crystal structure of 4-[(3-methoxyphenyl)carbamoyl]butanoic acid, C12H15NO4
  73. Crystal structure of dichlorido-bis(tri-4-tolylphosphane oxide-κO)-di(4-chlorophenyl-κC)tin(IV), C54H50Cl4O2P2Sn
  74. Crystal structure of dichloridodimethylbis(tri-4-tolylphosphane oxide-κO)-tin(IV), C44H48Cl2O2P2Sn
  75. Crystal structure of chlorido(2-methylquinolin-8-olato-κ2N,O)-bis(4-tolyl-κC)tin(IV), C24H22ClNOSn
  76. Crystal structure of (E)-dichloro(1-chloro-3-methoxyprop-1-en-2-yl)(4-methoxyphenyl)-λ4-tellane, C11H13Cl3O2Te
  77. Crystal structure of bis{N-methyl-N′-[3-(4-methoxyphenyl)-1-methylpropane-1-ylidene]carbamohydrazonothioato}zinc(II), C26H36N6O2S2Zn
  78. Crystal structure of (2-carboxy-4-(3-carboxy-5-carboxylatophenoxy)benzoato-κ2O,O′)bis(1,10-phenantroline-κ2N,N′)cobalt(II), C40H24N4O9Co
  79. The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5
  80. Crystal structure of (μ2-1,1′-bis(diphenylphosphino)ferrocene-κ2P,P′)-bis[(Z)N-(3-fluorophenyl)-O-methylthiocarbamato-S]digold(I) chloroform solvate, C50H42Au2F2FeN2O2P2S2, CHCl3
  81. Crystal structure of poly[bis(μ2-1,4-di(1H-imidazol-1-yl)benzene-κ2N:N′)-(μ2-tetraoxidomolybdato(VI)-κ2O:O′)cobalt(II)], C24H20N8O4MoCo
Downloaded on 16.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2020-0360/html?srsltid=AfmBOop-kM-mPJqKX2KNiNZC70FVHGqOqCZwFWUoFbRvER8tSpohc_tj
Scroll to top button